Identification and prioritization of novel therapeutic candidates against glutamate racemase from Klebsiella pneumoniae.
<h4>Background</h4>Klebsiella pneumoniae, a gram-negative bacterium in the Enterobacteriaceae family, is non-motile, encapsulated, and a major cause of nosocomial infections, particularly in intensive care units. The bacterium possesses a thick polysaccharide capsule and fimbriae, which...
Saved in:
Main Authors: | Ankit Kumar, Farah Anjum, Md Imtaiyaz Hassan, Anas Shamsi, Rashmi Prabha Singh |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2025-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0317622 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Structure-guided identification of mitogen-activated protein kinase-1 inhibitors towards anticancer therapeutics.
by: Md Nayab Sulaimani, et al.
Published: (2025-01-01) -
Genetically Engineered Bacterial Ghosts as Vaccine Candidates Against <i>Klebsiella pneumoniae</i> Infection
by: Svetlana V. Dentovskaya, et al.
Published: (2025-01-01) -
<i>Klebsiella pneumoniae</i> Phage M198 and Its Therapeutic Potential
by: Lika Leshkasheli, et al.
Published: (2025-01-01) -
Ceftazidime-avibactam susceptibility against Escherichia coli and Klebsiella pneumoniae
by: Arun Sachu, et al.
Published: (2025-02-01) -
Genome Characteristic of NDM-5-Producing Klebsiella Quasipneumoniae and Klebsiella Pneumoniae in China
by: Chen L, et al.
Published: (2025-02-01)